HLS Therapeutics Inc.

Stewards of Trusted Brands HLS Therapeutics Inc. (TSX:HLS) specializes in the acquisition and commercialization of pharmaceuticals focused on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. We are dedicated to introducing novel therapies in Canada and the United States and ensuring that trusted branded medicines are readily accessible to healthcare providers & patients. Led by a team of executives with deep expertise in product development and commercialization, HLS Therapeutics Inc. maintains operational locations in the Toronto, Montreal, and Philadelphia metropolitan areas. Experienced across all stages of the product lifecycle Our team has a wealth of experience with each stage of the pharmaceutical lifecycle, from late-stage development to new product launch and commercial-stage promotion. Our team is committed to expanding access to quality treatments critical to healthcare providers, patients, and their caregivers.